Get Started
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Get in TouchPreclinical Testing
Made Easy
Efficient formulation for large preclinical studies.
Easy scale-up of formulations developed on the NanoAssemblr® Ignite.
Greater formulation capacity with the simplicity and efficiency of the NanoAssemblr® Ignite.
Validation of Inline Dilution up to 5L, up to 50 L with Blaze+.
Formulation of 10 mL to 1L batches, up to 10 L with the Blaze+.
Scale-up development of upstream and downstream processes.
Up to 10 Liters per formulation
Connect bioprocess bags for closed system
Reduce cost by performing process development in house
Accelerate timelines by performing large scale formulations
Particle Size, Polydispersity and RNA Encapsulation Efficiency were Consistent as Production of Epo-encoded mRNA-LNP was Scaled using the NanoAssemblr® Platform
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Get in Touch1
An aqueous phase and a miscible solvent containing dissolved nanoparticle precursors are injected into each inlet of the NanoAssemblr cartridge2
Under laminar flow, the two phases do not immediately mix3
Microscopic features engineered into the channel reproducibly control the mixing of the two streams4
Rapid, controlled, homogenous mixing produces homogeneous nanoparticles
Blaze Formulation Demonstration Video
Blaze Informational Presentation
Blaze Demonstration
Publication - Abstract
November 29, 2018
International Journal of Pharmaceutics
Application Note
July 01, 2018
Poster
June 11, 2018
Poster
April 01, 2018
Poster
March 06, 2018